Summary
The purpose of this study was to define the role of beta-adrenergic blockade and direct membrane effects in the ability of dl-propranolol to alter ventricular repolarization and refractoriness in the intact heart. The effective refractory period (ERP) and the local Q-T interval were measured at an epicardial site in the left ventricle in 14 open-chest dogs anesthetized with alpha-chloralose. Beta-adrenergic influences were eliminated in seven dogs (group 1) by stellate transection and nadolol (0.5 mg/kg IV), and enhanced in seven dogs (group 2) by stellate transection and stimulation of the left ansae subclavia. Each dog received an initial beta-blocking dose of propranolol (0.5 mg/kg) followed by a second, cumulative dose of 5.0 mg/kg. In group 1 dogs, there was no significant change in either the ERP or local Q-T interval in response to the first dose of propranolol. In group 2 dogs, left stellate stimulation significantly shortened the ERP (20±2 msec) and the local Q-T interval (17±4 msec). The first dose of propranolol prolonged these parameters to values not different from prestimulation control values. There was no change in the H-V interval, QRS complex duration, or diastolic threshold (DT) in either group after the initial propranolol dose. The second dose of propranolol significantly shortened the ERP (5±1 msec) and the local Q-T interval (11±2 msec) in both groups. This dose also significantly increased the DT, H-V interval, and QRS complex duration. In three additional nadolol-treated dogs, a single 5 mg/kg dose of propranolol shifted the entire strength-interval curve 4 to 7 msec earlier into electrical diastole. The data indicate that a beta-blocking dose of propranolol prolongs repolarization and refractoriness only when adrenergic input is elevated. In the absence of beta-adrenergic influences, high doses of propranolol shorten repolarization and refractoriness. This latter effect may be due to a direct membrane effect of the drug.
Similar content being viewed by others
References
Morales-Aguilera A, Vaughan-Williams EM. The effects on cardiac muscle of beta-receptor antagonists in relation to their activity as local anesthetics.Br J Pharmacol 1981; 24:332–338.
Harry JD, Kappagoda CT, Linden RJ, et al. Action of propranolol on the dog heart.Cardiovasc Res 1973; 7:729–738.
Barrett AM, Cullum VA. The biological properties of the optical isomers of propranolol and their effects on cardiac arrhythmias.Br J Pharmacol 1968; 34:43–55.
Lucchesi BR, Whitsitt LS, Stickney JL. Antiarrhythmic effects of beta-adrenergic blocking agents.Ann NY Acad Sci 1967; 139:940–950.
Guidicelli J-F, Lhoste F, Boissier J-R. Beta-adrenergic blockade and atrioventricular conduction impairment.Eur J Pharmacol 1975; 31:216–225.
Kolman BS, Verrier RL, Lown B. Effect of vagus nerve stimulation upon excitability of the canine ventricle. Role of sympathetic-parasympathetic interactions.Am J Cardiol 1976; 37:1041–1045.
Dawson AK, Reele SB, Woosley RL, et al. Disparate physiological effects of a beta-agonist in the presence of high plasma propranolol.Clin Res 1979; 27:769A.
Brorson L, Reele S, Dupont W, et al. Effects of concentration and steric configuration of propranolol on AV conduction and ventricular repolarization in the dog.J Cardiovasc Pharmacol 1981; 3:692–703.
Amlie JP, Refsum H, Landmark KH. Prolonged ventricular refractoriness and action potential duration after beta-adrenoreceptor blockade in the dog heart in situ.J Cardiovasc Pharmacol 1982; 4:157–162.
Patterson E, Lucchesi BR. Antifibrillatory properties of the beta-adrenergic receptor antagonists, nadolol, sotalol, atenolol and propranolol, in the anesthetized dog.Pharmacology 1984; 28:121–129.
Pierpont GL, DeMaster EG, Cohn JN. Regional differences in adrenergic function within the left ventricle.Am J Physiol 1984; 246: H824-H829.
Kralios FA, Martin L, Burgess MJ, et al. Local ventricular repolarization changes due to sympathetic nerve branch stimulation.Am J Physiol 1975; 228:1621–1626.
Levy MN, Ng M, Zieske H. Functional distribution of the peripheral cardiac sympathetic pathways.Circ Res 1966; 19:650–661.
Mizeres NJ. The origin and course of the cardioaccelerator fibers in the dog heart.Anat Rec 1958; 132:261–279.
Randall WC, McNally H, Cowan J, et al. Functional analysis of the cardioaugmenter and cardioaccelerator pathways in the dog.Am J Physiol 1957; 191:213–217.
Lee RJ, Evans DB, Baky SH, et al. Pharmacology of nadolol (SQ 11725), a beta-adrenergic antagonist lacking direct myocardial depression.Eur J Pharmacol 1975; 33: 371–382.
Spear JF, Moore NE, Horowitz LN. Effect of current pulses delivered during the ventricular vulnerable period upon the ventricular fibrillation threshold.Am J Cardiol 1973; 32:814–822.
Martins JB, Zipes DP, Lund DD. Distribution of local repolarization changes produced by efferent vagal stimulation in the canine ventricles.J Am Coll Cardiol 1983;2:1191–1199.
Howe R, Shanks RG. Optical isomers of propranolol.Nature 1966; 210:1336–1338.
Barrett AM. A comparison of the effects of (±)-propranolol and (+)-propranolol in anaesthetized dogs; beta-receptor blocking and haemodynamic action.J Pharm Pharmacol 1969; 21:241–247.
Hayes A, Cooper RG. Studies on the absorption, distribution and excretion of propranolol in rat, dog and monkey.J Pharmacol Exp Ther 1971; 176:302–311.
Brooks C McC, Hoffman BF, Suckling EE, et al. Excitability of the heart. New York: Grune & Stratton, 1955; 216.
Priola DV. Effects of beta-receptor stimulation and blockade on A-V nodal and bundle branch conduction in the heart.Circ Res 1964; 14:86–92.
Wallace AG, Sarnoff SJ. Effects of cardiac sympathetic nerve stimulation on conduction in the heart.Circ Res 1964; 14:86–92.
Dukes ID, Vaughan Williams EM. Effects of selective α1-, α2-, β1- and β2-adrenoceptor stimulation on potentials and contractions in the rabbit heart.J Physiol 1984; 355:523–546.
Martins JB. Evidence against alpha-receptor mediated electrophysiologic effects in canine ventricular muscle (abstr).Fed Proc 1985; 44:807.
Morales-Aquilera A, Vaughan Williams EM. The effects on cardiac muscle of beta-receptor antagonists in relation to their activity as local anaesthetics.Br J Pharmacol 1965; 24:332–338.
Hondeghem LM, Katzung BG. Time and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels.Biochim Biophys Acta 1977; 472:373–398.
Rosen MR, Wit AL. Electropharmacology of antiarrhythmic drugs.Am Heart J 1983; 106:829–839.
Davis LD, Tempte JV. Effects of propranolol on the transmembrane potentials of ventricular muscle and Purkinje fibers of the dog.Circ Res 1968; 22:661–667.
Pruett JK, Walle T, Walle UK. Propranolol effects on membrane repolarization time in isolated canine Purkinje fibers: Threshold tissue content and the influence of exposure time.J Pharmacol Exp Ther 1980; 215:539–543.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Euler, D.E., Scanlon, P.J. Effect of propranolol on ventricular repolarization and refractoriness: Role of beta-blockade versus direct membrane effects. Cardiovasc Drug Ther 1, 605–612 (1988). https://doi.org/10.1007/BF02125746
Issue Date:
DOI: https://doi.org/10.1007/BF02125746